论文部分内容阅读
目的探讨血塞通联合依达拉奉对脑梗死的治疗效果。方法研究的88例对象均为我院2015年10月-2016年10月期间收治的脑梗死患者,按照双盲法将其分为两组。分为两组分别用丹参注射液治疗和血塞通联合依达拉奉治疗。治疗结束后,观察两组患者治疗效果,采用脑梗死神经功能缺损评估表NIHSS对治疗前后患者情况进行评分。结果两组患者治疗后NIHSS评分均有显著改善,且观察组显著优于对照组,差异有统计学意义(P<0.05)。结论脑梗死的治疗周期较长,患者依从性较低,临床上可给予血塞通联合依达拉奉治疗,不但疗效好,且能显著改善患者神经功能缺损情况,值得推广。
Objective To investigate the therapeutic effect of Xuesaitong combined with edaravone on cerebral infarction. Methods 88 cases of patients were admitted to our hospital from October 2015 to October 2016 were treated patients with cerebral infarction, according to double-blind method is divided into two groups. Divided into two groups were treated with Salvia injection and Xuesaitong combined edaravone treatment. After the treatment, the therapeutic effect of the two groups was observed. The NIHSS score of cerebral infarction neurological deficit score was used to evaluate the patients before and after treatment. Results NIHSS scores of both groups were significantly improved after treatment, and the observation group was significantly better than the control group, the difference was statistically significant (P <0.05). Conclusions The treatment period of cerebral infarction is longer and the patient compliance is lower. Xuesaitong combined with edaravone can be given clinically. Not only the curative effect is good, but also the neurological deficit of patients can be remarkably improved.